Progress in the treatment of infantile hemangioma

Abstract

Infantile hemangioma (IH) is a common benign tumor, which mostly resolves spontaneously; however, children with high-risk IH need treatment. To compare the efficacy of single drug pharmacotherapy and combined drugs pharmacotherapy for a spectrum of Infantile Cutaneous Hemangiomas ranging from smaller and simpler lesions to large and complicated lesions selectively chosen. It is a Retrospective and Prospective study done for 2yrs. All children less than 2 years of age, with Infantile Cutaneous Hemangiomas. Infantile Cutaneous Hemangiomas not amenable for complete primary excision because of size and site of lesion are included in the study. Children with Infantile Cutaneous Hemangiomas presenting after 2 years of age and Hemangiomas associated with Visceral Hemangiomas. Infantile hemangiomas (IHs) are the most-common soft-tissue tumors of infancy, occurring in 4% to 10% of children under 1 year of age, with a clear female to male predominance of 2.5 – 4:1­. 27(64.2%) presented with lesion in the head and neck region. Three (3) out of the 42 presented (7.1%) on the chest. Four (4) out of the 42 (9.5%) presented on the Anterior abdominal wall.